Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-39758979 in Persistent Asthma
NCT00946569Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Aug 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of JNJ-39758979 in persistent asthma, sponsored by Johnson & Johnson. Started Aug 2009; status: completed.
02
Drugs
JNJ-39758979
03
Conditions
persistent asthma
Beyond the preview
Go deeper on NCT00946569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00946569.